According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent ...

EYLEA HD is anticipated to gain traction with the launch of a prefilled syringe in mid-2025 and label expansions for macular edema and extended dosing intervals. Management believes these developments ...

Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...

Sanofi in partnership with Regeneron to present 24 abstracts across approved and investigational medicines at AAAAI Annual Meeting in San Diego: Paris Friday, February 7, 2025, 12 ...

Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, ...

A new study found that the proportion of people being diagnosed with lung cancer who have never smoked is increasing, and air ...

Air pollution is fueling a rise in the commonest form of lung cancer among non-smokers, hitting women and people in southeast ...

A new study found an increase in adenocarcinoma, a lung cancer that is most commonly associated with nonsmokers.

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...

Since the wildfires, Dr. Philip Amoils is seeing more patients with bronchitis, chronic sinusitis, congestion and asthma.

The proportion of people who have never smoked being diagnosed with lung cancer is rising, with new research pointing to air pollution as a growing contributor to lung cancer around the world.